Clinical trial
Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of…
NCT00330096 · Société des Produits Nestlé (SPN), Industry · Completed
Key facts
| NCT number | NCT00330096 |
|---|---|
| Title | Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women |
| Lead sponsor | Société des Produits Nestlé (SPN), Industry |
| Collaborators | Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement Centre de Recherche en Nutrition Humaine. Clermont-Ferrand, France |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Osteopenia |
| Intervention type | Drug, Other |
| Interventions | Hesperidin, Placebo |
| Enrollment | 110 |
| Start date | Mar 1, 2006 |
| Completion | Apr 1, 2009 |
| First posted | May 25, 2006 |
| Last update posted | Oct 29, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: